Population-level diversity-disease relationship (p-DDR) in the human microbiome associated diseases

Diversity-disease relationship (DDR) is a de facto standard analysis in the studies of human microbiome associated diseases (MADs). For example, the species richness or Shannon entropy are routinely compared between the healthy and diseased groups. Nevertheless, the basic scale of the standard diver...

Full description

Bibliographic Details
Main Authors: Wendy Li, Zhanshan (Sam) Ma
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037021001446
id doaj-389e62aa1616494da6995e14252ef24b
record_format Article
spelling doaj-389e62aa1616494da6995e14252ef24b2021-04-30T07:21:13ZengElsevierComputational and Structural Biotechnology Journal2001-03702021-01-011922972306Population-level diversity-disease relationship (p-DDR) in the human microbiome associated diseasesWendy Li0Zhanshan (Sam) Ma1Computational Biology and Medical Ecology Lab, State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, China; Kunming College of Life Sciences, University of Chinese Academy of Sciences, ChinaComputational Biology and Medical Ecology Lab, State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, China; Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming, China; Kunming College of Life Sciences, University of Chinese Academy of Sciences, China; Corresponding author at: Computational Biology and Medical Ecology Lab, State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, China.Diversity-disease relationship (DDR) is a de facto standard analysis in the studies of human microbiome associated diseases (MADs). For example, the species richness or Shannon entropy are routinely compared between the healthy and diseased groups. Nevertheless, the basic scale of the standard diversity analysis is individual subject rather than a cohort or population because the diversity is computed for individual samples, not for the group. Here we aim to expand the current DDR study from individual focus to population level, which can offer important insights for understanding the epidemiology of MADs. We analyzed the diversity-disease relationship at cohort scale based on a collection of 23 datasets covering the major human MADs. Methodologically, we harness the power of a recent extension to the classic species-area relationship (SAR), i.e., the diversity-area relationship (DAR), to achieve the expansion from individual DDR to inter-subject diversity scaling analysis. Specifically, we apply the DAR analysis to estimate and compare the potentially maximal accrual diversities of the healthy and diseases groups, as well as the inter-subject diversity scaling parameters and the individual-to-population diversity ratios. It was shown that, except for the potential diversity (Dmax) at the cohort level in approximately 5.4% cases of MADs, DAR parameters displayed no significant differences between healthy and diseased treatments. That is, the DAR parameters are rather resilient against MADs, except for the potential diversity in some diseases. We compared our population-level DDR with the existing individual-level DDR patterns and proposed a hypothesis to interpret their differences.http://www.sciencedirect.com/science/article/pii/S2001037021001446Diversity-disease relationship (DDR)Population-level diversity-disease relationship (P-DDR)Diversity-area relationship (DAR)Microbiome-associated disease (MAD)Species-area relationship (SAR)Potential microbiome diversity
collection DOAJ
language English
format Article
sources DOAJ
author Wendy Li
Zhanshan (Sam) Ma
spellingShingle Wendy Li
Zhanshan (Sam) Ma
Population-level diversity-disease relationship (p-DDR) in the human microbiome associated diseases
Computational and Structural Biotechnology Journal
Diversity-disease relationship (DDR)
Population-level diversity-disease relationship (P-DDR)
Diversity-area relationship (DAR)
Microbiome-associated disease (MAD)
Species-area relationship (SAR)
Potential microbiome diversity
author_facet Wendy Li
Zhanshan (Sam) Ma
author_sort Wendy Li
title Population-level diversity-disease relationship (p-DDR) in the human microbiome associated diseases
title_short Population-level diversity-disease relationship (p-DDR) in the human microbiome associated diseases
title_full Population-level diversity-disease relationship (p-DDR) in the human microbiome associated diseases
title_fullStr Population-level diversity-disease relationship (p-DDR) in the human microbiome associated diseases
title_full_unstemmed Population-level diversity-disease relationship (p-DDR) in the human microbiome associated diseases
title_sort population-level diversity-disease relationship (p-ddr) in the human microbiome associated diseases
publisher Elsevier
series Computational and Structural Biotechnology Journal
issn 2001-0370
publishDate 2021-01-01
description Diversity-disease relationship (DDR) is a de facto standard analysis in the studies of human microbiome associated diseases (MADs). For example, the species richness or Shannon entropy are routinely compared between the healthy and diseased groups. Nevertheless, the basic scale of the standard diversity analysis is individual subject rather than a cohort or population because the diversity is computed for individual samples, not for the group. Here we aim to expand the current DDR study from individual focus to population level, which can offer important insights for understanding the epidemiology of MADs. We analyzed the diversity-disease relationship at cohort scale based on a collection of 23 datasets covering the major human MADs. Methodologically, we harness the power of a recent extension to the classic species-area relationship (SAR), i.e., the diversity-area relationship (DAR), to achieve the expansion from individual DDR to inter-subject diversity scaling analysis. Specifically, we apply the DAR analysis to estimate and compare the potentially maximal accrual diversities of the healthy and diseases groups, as well as the inter-subject diversity scaling parameters and the individual-to-population diversity ratios. It was shown that, except for the potential diversity (Dmax) at the cohort level in approximately 5.4% cases of MADs, DAR parameters displayed no significant differences between healthy and diseased treatments. That is, the DAR parameters are rather resilient against MADs, except for the potential diversity in some diseases. We compared our population-level DDR with the existing individual-level DDR patterns and proposed a hypothesis to interpret their differences.
topic Diversity-disease relationship (DDR)
Population-level diversity-disease relationship (P-DDR)
Diversity-area relationship (DAR)
Microbiome-associated disease (MAD)
Species-area relationship (SAR)
Potential microbiome diversity
url http://www.sciencedirect.com/science/article/pii/S2001037021001446
work_keys_str_mv AT wendyli populationleveldiversitydiseaserelationshippddrinthehumanmicrobiomeassociateddiseases
AT zhanshansamma populationleveldiversitydiseaserelationshippddrinthehumanmicrobiomeassociateddiseases
_version_ 1721498580512931840